Profil
Malcolm Paul Fairbairn is the founder of Ascend Capital LLC, which was founded in 1999.
He is currently a Partner at Transcend Partners LLC.
Mr. Fairbairn's former jobs include Managing Director at Citadel Investment Group, Inc. in 1999, Independent Director at TFF Pharmaceuticals, Inc., and Senior Analyst at Strome Susskind Investment Management LP.
Mr. Fairbairn's education includes undergraduate and graduate degrees from Massachusetts Institute of Technology and an MBA from Harvard Business School, which he received in 1994.
Postes actifs de Malcolm Fairbairn
| Sociétés | Poste | Début |
|---|---|---|
Transcend Partners LLC
Transcend Partners LLC Investment ManagersFinance Profile Unavailable. | Directeur Général | - |
Anciens postes connus de Malcolm Fairbairn
| Sociétés | Poste | Fin |
|---|---|---|
Citadel Investment Group, Inc.
Citadel Investment Group, Inc. Investment ManagersFinance Provides investment banking, institutional trading, and fund administration services | Corporate Officer/Principal | 31/03/1999 |
Strome Susskind Investment Management LP | Corporate Officer/Principal | - |
| TFF PHARMACEUTICALS, INC. | Directeur/Membre du Conseil | - |
Ascend Capital LLC
Ascend Capital LLC Investment ManagersFinance Ascend Capital employs an opportunistic US-focused long/short equity investment strategy. They seek to generate superior risk-adjusted returns that maximize gains and minimize volatility over a broad range of market environments. They employ a variation of the Jones Model investing strategy with the intention of achieving capital appreciation in a broad range of market environments. The net market exposure of each account may vary significantly depending on the firm's assessment of shifting economic and market conditions, as well as particular long and short investing opportunities. Ascend Capital's strategy has neither a long nor short bias. Although their strategy focuses on equity and equity-related securities that are publicly traded, they may pursue a highly diverse range of investments and trading strategies. Ascend Capital may cause the accounts to invest a significant portion of their assets in one or more of the following: illiquid securities, including privately placed equity (of public and private companies), defaulted debt, bank debt and trade claims, bonds (convertible and non-convertible), other fixed-income investments and senior and subordinated tranches of asset-backed pools. Ascend Capital's strategy includes short selling. They expect the funds to utilize leverage on a moderate to extensive basis. The separate accounts utilize leverage in accordance with the investment guidelines for each account. The firm may cause the accounts to buy or sell (write) options, publicly traded and over-the-counter, covered and uncovered, on securities and securities indices, as well as options and forward contracts on currencies. They may also cause the accounts to engage in a variety of investment techniques involving arbitrage. addition, they may cause the accounts to engage in futures and other derivative transactions, typically for hedging of existing long and short positions. | Directeur Général | - |
Formation de Malcolm Fairbairn
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 7 |
|---|---|
Strome Susskind Investment Management LP | |
Ascend Capital LLC
Ascend Capital LLC Investment ManagersFinance Ascend Capital employs an opportunistic US-focused long/short equity investment strategy. They seek to generate superior risk-adjusted returns that maximize gains and minimize volatility over a broad range of market environments. They employ a variation of the Jones Model investing strategy with the intention of achieving capital appreciation in a broad range of market environments. The net market exposure of each account may vary significantly depending on the firm's assessment of shifting economic and market conditions, as well as particular long and short investing opportunities. Ascend Capital's strategy has neither a long nor short bias. Although their strategy focuses on equity and equity-related securities that are publicly traded, they may pursue a highly diverse range of investments and trading strategies. Ascend Capital may cause the accounts to invest a significant portion of their assets in one or more of the following: illiquid securities, including privately placed equity (of public and private companies), defaulted debt, bank debt and trade claims, bonds (convertible and non-convertible), other fixed-income investments and senior and subordinated tranches of asset-backed pools. Ascend Capital's strategy includes short selling. They expect the funds to utilize leverage on a moderate to extensive basis. The separate accounts utilize leverage in accordance with the investment guidelines for each account. The firm may cause the accounts to buy or sell (write) options, publicly traded and over-the-counter, covered and uncovered, on securities and securities indices, as well as options and forward contracts on currencies. They may also cause the accounts to engage in a variety of investment techniques involving arbitrage. addition, they may cause the accounts to engage in futures and other derivative transactions, typically for hedging of existing long and short positions. | Finance |
Massachusetts Institute of Technology
Massachusetts Institute of Technology Finance/Rental/LeasingFinance Functions as a College/University | Finance |
Citadel Investment Group, Inc.
Citadel Investment Group, Inc. Investment ManagersFinance Provides investment banking, institutional trading, and fund administration services | Finance |
Harvard Business School
Harvard Business School Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
TFF Pharmaceuticals, Inc.
TFF Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Manufactures inhaled dry powder drugs for the treatment of pulmonary diseases and conditions | Health Technology |
Transcend Partners LLC
Transcend Partners LLC Investment ManagersFinance Profile Unavailable. | Finance |
















